A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.

MLA

Crocenzi, Todd, et al. “A Hypofractionated Radiation Regimen Avoids the Lymphopenia Associated with Neoadjuvant Chemoradiation Therapy of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.” Journal for Immunotherapy of Cancer, vol. 4, Aug. 2016, p. 45. EBSCOhost, https://doi.org/10.1186/s40425-016-0149-6.

APA

Crocenzi, T., Cottam, B., Newell, P., Wolf, R. F., Hansen, P. D., Hammill, C., Solhjem, M. C., To, Y.-Y., Greathouse, A., Tormoen, G., Jutric, Z., Young, K., Bahjat, K. S., Gough, M. J., & Crittenden, M. R. (2016). A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma. Journal for Immunotherapy of Cancer, 4, 45. https://doi.org/10.1186/s40425-016-0149-6

Chicago

Crocenzi, Todd, Benjamin Cottam, Pippa Newell, Ronald F Wolf, Paul D Hansen, Chet Hammill, Matthew C Solhjem, et al. 2016. “A Hypofractionated Radiation Regimen Avoids the Lymphopenia Associated with Neoadjuvant Chemoradiation Therapy of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.” Journal for Immunotherapy of Cancer 4 (August): 45. doi:10.1186/s40425-016-0149-6.